Apollo Hospitals Enterprise Stock Current Valuation
| APOLLOHOSP | 6,520 124.90 1.88% |
Valuation analysis of Apollo Hospitals Ent helps investors to measure Apollo Hospitals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of now, Apollo Hospitals' Total Cash From Operating Activities is increasing as compared to previous years. The Apollo Hospitals' current Other Cashflows From Investing Activities is estimated to increase to about 526.5 M, while Cash is projected to decrease to under 3.2 B. Fundamental drivers impacting Apollo Hospitals' valuation include:
Price Book 12.7369 | Enterprise Value 994.7 B | Enterprise Value Ebitda 33.4221 | Price Sales 4.4333 | Forward PE 47.619 |
Fairly Valued
Today
Please note that Apollo Hospitals' price fluctuation is very steady at this time. Calculation of the real value of Apollo Hospitals Ent is based on 3 months time horizon. Increasing Apollo Hospitals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Apollo Hospitals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Apollo Stock. However, Apollo Hospitals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6519.8 | Real 6445.36 | Hype 6660.11 | Naive 6951.53 |
The intrinsic value of Apollo Hospitals' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Apollo Hospitals' stock price.
Estimating the potential upside or downside of Apollo Hospitals Enterprise helps investors to forecast how Apollo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Apollo Hospitals more accurately as focusing exclusively on Apollo Hospitals' fundamentals will not take into account other important factors: Apollo Hospitals Enterprise Company Current Valuation Analysis
Apollo Hospitals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Apollo Hospitals Current Valuation | 994.68 B |
Most of Apollo Hospitals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apollo Hospitals Enterprise is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Apollo Hospitals Enterprise has a Current Valuation of 994.68 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is significantly lower than that of the firm.
Apollo Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apollo Hospitals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apollo Hospitals could also be used in its relative valuation, which is a method of valuing Apollo Hospitals by comparing valuation metrics of similar companies.Apollo Hospitals is rated below average in current valuation category among its peers.
Apollo Fundamentals
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0723 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 994.68 B | ||||
| Shares Outstanding | 143.78 M | ||||
| Shares Owned By Insiders | 30.81 % | ||||
| Shares Owned By Institutions | 47.67 % | ||||
| Price To Book | 12.74 X | ||||
| Price To Sales | 4.43 X | ||||
| Revenue | 190.59 B | ||||
| Gross Profit | 73.38 B | ||||
| EBITDA | 24.02 B | ||||
| Net Income | 8.99 B | ||||
| Cash And Equivalents | 483 M | ||||
| Total Debt | 53.33 B | ||||
| Book Value Per Share | 499.31 X | ||||
| Cash Flow From Operations | 19.2 B | ||||
| Earnings Per Share | 91.28 X | ||||
| Target Price | 7813.97 | ||||
| Number Of Employees | 83.15 K | ||||
| Beta | 0.68 | ||||
| Market Capitalization | 937.45 B | ||||
| Total Asset | 167.53 B | ||||
| Retained Earnings | 39.11 B | ||||
| Working Capital | 6.15 B | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 167.53 B | ||||
| Last Dividend Paid | 19.0 |
About Apollo Hospitals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apollo Hospitals Enterprise's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apollo Hospitals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apollo Hospitals Enterprise based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Apollo Stock
Apollo Hospitals financial ratios help investors to determine whether Apollo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Apollo with respect to the benefits of owning Apollo Hospitals security.